JP2019533652A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533652A5 JP2019533652A5 JP2019517257A JP2019517257A JP2019533652A5 JP 2019533652 A5 JP2019533652 A5 JP 2019533652A5 JP 2019517257 A JP2019517257 A JP 2019517257A JP 2019517257 A JP2019517257 A JP 2019517257A JP 2019533652 A5 JP2019533652 A5 JP 2019533652A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- cdk1
- clk2
- cell
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C)[n]1c2nc(N[C@@]3C*CC3)nc(Nc3cccc(Cl)c3)c2nc1 Chemical compound CC(C)[n]1c2nc(N[C@@]3C*CC3)nc(Nc3cccc(Cl)c3)c2nc1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662402876P | 2016-09-30 | 2016-09-30 | |
| US62/402,876 | 2016-09-30 | ||
| PCT/US2017/054442 WO2018064545A1 (en) | 2016-09-30 | 2017-09-29 | Dual clk/cdk1 inhibitors for cancer treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019533652A JP2019533652A (ja) | 2019-11-21 |
| JP2019533652A5 true JP2019533652A5 (2) | 2020-11-12 |
Family
ID=61760971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517257A Pending JP2019533652A (ja) | 2016-09-30 | 2017-09-29 | がんを処置するための二重ｃｌｋ／ｃｄｋ１阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10722515B2 (2) |
| EP (2) | EP3518925A4 (2) |
| JP (1) | JP2019533652A (2) |
| CN (2) | CN114149432B (2) |
| WO (1) | WO2018064545A1 (2) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR108325A1 (es) | 2016-04-27 | 2018-08-08 | Samumed Llc | Isoquinolin-3-il carboxamidas y preparación y uso de las mismas |
| US10722515B2 (en) | 2016-09-30 | 2020-07-28 | Sri International | Dual CLK/CDK1 inhibitors for cancer treatment |
| EP3813826A4 (en) * | 2018-06-26 | 2022-07-06 | BioSplice Therapeutics, Inc. | METHOD OF TREATMENT OF CANCER USING A CLK INHIBITOR |
| TW202202498A (zh) * | 2020-07-01 | 2022-01-16 | 大陸商四川海思科製藥有限公司 | 一種並環雜環衍生物及其在醫藥上的應用 |
| CN113384703B (zh) * | 2021-06-21 | 2023-03-10 | 深圳市第二人民医院(深圳市转化医学研究院) | Dhx34基因的表达抑制剂在制备抑制肝癌细胞转移和侵袭的药物中的应用 |
| CN120289460A (zh) * | 2024-01-09 | 2025-07-11 | 中国科学院合肥物质科学研究院 | 含有嘌呤环的化合物及其用途 |
| WO2025243082A2 (en) * | 2024-05-24 | 2025-11-27 | The Chinese University Of Hong Kong | Covalent protein-protein interaction inhibitor against srpks |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR901464A (fr) | 1943-01-23 | 1945-07-27 | Boehringer & Soehne Gmbh | Procédé d'obtention de vanilline |
| AU7296896A (en) * | 1995-11-01 | 1997-05-22 | Novartis Ag | Purine derivatives and processes for their preparation |
| GB9903762D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
| FR2793794B1 (fr) * | 1999-05-21 | 2001-07-27 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| JP2003531111A (ja) * | 1999-12-17 | 2003-10-21 | アライアッド・ファーマシューティカルズ・インコーポレーテッド | プロトンポンプインヒビター |
| DE60031886T2 (de) * | 1999-12-17 | 2007-09-06 | Ariad Pharmaceuticals, Inc., Cambridge | Purinderivate |
| AU2583901A (en) * | 1999-12-17 | 2001-06-25 | Ariad Pharmaceuticals, Inc. | Proton pump inhibitors |
| US7723340B2 (en) * | 2005-01-13 | 2010-05-25 | Signal Pharmaceuticals, Llc | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| WO2009085226A2 (en) * | 2007-12-21 | 2009-07-09 | Sirtris Pharmaceuticals, Inc. | Inhibitors of cdc2-like kinases (clks) and methods of use thereof |
| US9908884B2 (en) * | 2009-05-05 | 2018-03-06 | Dana-Farber Cancer Institute, Inc. | EGFR inhibitors and methods of treating disorders |
| WO2013144532A1 (en) * | 2012-03-30 | 2013-10-03 | Astrazeneca Ab | 3 -cyano- 5 -arylamino-7 -cycloalkylaminopyrrolo [1, 5 -a] pyrimidine derivatives and their use as antitumor agents |
| JP6286421B2 (ja) * | 2012-05-15 | 2018-02-28 | サイクラセル リミテッド | サパシタビン及びセリシクリブの投与レジメン |
| AU2014244083B2 (en) * | 2013-03-13 | 2018-09-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods for modulating chemotherapeutic cytotoxicity |
| UA115388C2 (uk) * | 2013-11-21 | 2017-10-25 | Пфайзер Інк. | 2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань |
| US11702630B2 (en) | 2016-05-31 | 2023-07-18 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | In vitro methods of differentiating stem cells into neurons and neurons generated using the same |
| US10722515B2 (en) * | 2016-09-30 | 2020-07-28 | Sri International | Dual CLK/CDK1 inhibitors for cancer treatment |
-
2017
- 2017-09-29 US US16/334,229 patent/US10722515B2/en active Active
- 2017-09-29 EP EP17857539.5A patent/EP3518925A4/en not_active Withdrawn
- 2017-09-29 WO PCT/US2017/054442 patent/WO2018064545A1/en not_active Ceased
- 2017-09-29 CN CN202111328981.9A patent/CN114149432B/zh active Active
- 2017-09-29 EP EP22165211.8A patent/EP4086257A1/en not_active Withdrawn
- 2017-09-29 CN CN201780067717.XA patent/CN109937039A/zh active Pending
- 2017-09-29 JP JP2019517257A patent/JP2019533652A/ja active Pending
-
2020
- 2020-05-28 US US16/886,290 patent/US11337981B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019533652A5 (2) | ||
| JP2017008088A5 (2) | ||
| CN113767106A (zh) | 氧杂氮杂喹唑啉-7(8h)-酮类化合物,其制法与医药上的用途 | |
| JP2018536636A5 (2) | ||
| JP2023506530A5 (2) | ||
| RU2013102398A (ru) | Лечение рака крови | |
| JP2019510746A5 (2) | ||
| JP2016515561A5 (2) | ||
| JP2023522250A5 (2) | ||
| JP2020514356A5 (2) | ||
| JP2018535951A5 (2) | ||
| JP2019501204A5 (2) | ||
| KR20180043356A (ko) | 담관암의 치료법 | |
| JP2013527249A5 (2) | ||
| JP2014510729A5 (2) | ||
| JP2018534288A5 (2) | ||
| JP2016529285A5 (2) | ||
| JP2021080296A5 (2) | ||
| JP2017513908A5 (2) | ||
| JP2015500884A5 (2) | ||
| JP2015523346A5 (2) | ||
| JP2018535989A5 (2) | ||
| JP2016517843A5 (2) | ||
| JP2020512977A5 (2) | ||
| CN110139863A (zh) | 作为雌激素受体降解剂的吲哚并取代哌啶类化合物 |